Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 424B5: Prospectus
Revance Therapeutics | 424B5: Prospectus
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Revance Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144